Neogen Corporation
Moat Score — Neogen Corporation
Total Moat Score
16 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 4 / 5 | Neogen's diagnostic assays (Petrifilm, Veratox, ANSR) carry decades of regulatory validation and brand recognition inherited in part from 3M's Food Safety Division, and its genomics platforms (GeneSeek, Igenity) represent proprietary testing IP that is difficult and slow for a new entrant to replicate. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 2 / 5 | The 2022 combination with 3M's Food Safety Division gave Neogen meaningfully larger manufacturing scale, but fiscal 2025 gross margin fell to 47.1% from 50.2%, showing integration has not yet converted that scale into a clear structural cost advantage over competitors. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 3 / 5 | Because food-safety testing is driven by regulatory and retailer requirements rather than discretionary demand, and a recall vastly outweighs the cost of testing, customers are relatively price-insensitive, though the recent margin compression suggests this pricing power is being tested by integration and competitive dynamics. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | Neogen's genomics services (GeneSeek, Igenity) improve modestly as more livestock genetic data accumulates in its databases, but this is a weak, narrow effect rather than a broad network effect across the company's diagnostic test-kit business. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 4 / 5 | Once a food processor or lab validates its quality-control process around a specific Neogen assay for a given pathogen or allergen, switching to a competitor's kit requires costly re-validation of the testing method under regulatory and customer audit requirements, creating real stickiness. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 2 / 5 | Neogen's own 10-K notes no single competitor matches its combined breadth across food and animal safety, but it still faces well-resourced specialist competitors (Thermo Fisher, Bio-Rad, Zoetis, Elanco) in each individual product category, limiting how much efficient-scale protection the broad portfolio actually provides. |